MARKET

BCTXL

BCTXL

Briacell Therapeutics Corp
NASDAQ
1.000
+0.070
+7.53%
Closed 12:20 03/27 EDT
OPEN
0.9300
PREV CLOSE
0.9300
HIGH
1.000
LOW
0.9100
VOLUME
50.45K
TURNOVER
--
52 WEEK HIGH
1.400
52 WEEK LOW
0.6500
MARKET CAP
--
P/E (TTM)
-0.0307
1D
5D
1M
3M
1Y
5Y
1D
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/18 11:30
BriaCell reports 9 of 25 Phase 2 metastatic breast cancer patients alive more than 18-47 months post-enrollment
Reuters · 03/17 14:32
BriaCell Therapeutics Q2 FY2026 net loss widens 15% to USD 7.3 million
Reuters · 03/10 21:09
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/10 11:53
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
Barchart · 03/10 06:30
BriaPro to Buy BriaCell’s Exclusive Soluble CD80 License in Asset Deal
Reuters · 02/20 21:01
BriaPro to Buy BriaCell’s Exclusive Soluble CD80 License in Asset Deal
Reuters · 02/18 22:30
BRIACELL THERAPEUTICS CORP: AS PART OF TRANSACTION, BRIACELL WILL MAKE AVAILABLE TO BRIAPRO UP TO $3 MLN TO FUND RESEARCH AND DEVELOPMENT EFFORT
Reuters · 02/18 22:30
More

Webull offers undefined stock information, including NASDAQ: BCTXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXL stock methods without spending real money on the virtual paper trading platform.